91
Views
1
CrossRef citations to date
0
Altmetric
Research Article

GC-MS Based Profiling, Antimicrobial Activity and Cytotoxicity Studies of Camellia sinensis (L.) O. Kuntze Flower Extract

, , &
Pages 137-145 | Received 09 Nov 2021, Accepted 01 Mar 2022, Published online: 18 Apr 2022
 

Abstract

Camellia sinensis flowers are rich cradle of bioactive phytochemicals yet treated as waste biomass of the bush. However, flowers are used for the treatment of diverse health ailments since ages. Thus solvent free supercritical fluid extract of C. sinensis flowers was targeted to explore the phytochemical and bioactive potential. Parameters for the extraction were optimized at 300 bar pressure, temperature 45°C, static time 15-20 minutes and dynamic time 90 minutes that yield 1.005% (1.005g/100g) extract. The chemical characterization of extract (Gas chromatography-mass spectrometric analysis) resulted in the identification of eighteen non-polar compounds. Furthermore, derivatization (silylation) identified five unsaturated fatty acids and a terpene alcohol. The antimicrobial studies of C. sinensis flowers revealed strong antifungal (20-27 mm) and appreciable antibacterial (7-12 mm) potential at minimum concentrations (1 mg/mL). The cytotoxicity studies of tea flower extract against colorectal cancer cell lines (HCT-116 and HT-29) showed cell death up to 80±0.80% that highlighted the importance of economically underutilized tea flowers. This also revealed wide scope for their utilization in pharmaceutical, nutraceutical and cosmetic sectors.

GRAPHICAL ABSTRACT

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.